GHK-Cu is one of the most heavily studied small peptides in the literature, and one of the most frequently misdescribed. This article summarises what published research actually examines, where the evidence is strong, and where it stops.
What GHK-Cu is
GHK is a tripeptide with the sequence glycyl-L-histidyl-L-lysine. It was first isolated from human plasma, and it occurs naturally in a range of biological fluids. On its own it is a simple three-residue peptide. What makes it unusual is its affinity for copper(II) ions: GHK binds Cu2+ with high affinity, forming the complex normally written as GHK-Cu.
That distinction matters in a laboratory setting. GHK and GHK-Cu are not interchangeable reference materials, and a significant portion of the published literature concerns the copper-bound complex specifically rather than the free peptide.
Why the copper matters
Copper is a redox-active transition metal and a required cofactor for a number of enzymes, including lysyl oxidase and superoxide dismutase. Free copper ions in solution are problematic because they catalyse the generation of reactive oxygen species. The coordination chemistry of GHK-Cu is therefore central to why the complex is studied at all: the peptide acts as a carrier that holds copper in a defined coordination geometry rather than leaving it free in solution.
A 2026 systematic review examined these mechanisms alongside delivery approaches, and the coordination behaviour of the complex remains an active area of formulation research.[3]
What the published research examines
Matrix metalloproteinases and tissue remodelling
One of the earlier and more frequently cited studies looked at matrix metalloproteinase (MMP) expression and activation in wound models, and how the tripeptide-copper complex modulated them.[2] MMPs are the enzyme family responsible for degrading and remodelling extracellular matrix components such as collagen, so their regulation is a reasonable mechanistic target for a compound studied in connective tissue contexts.
Pickart's 2008 review in Journal of Biomaterials Science, Polymer Edition drew this work together under the broader heading of tissue remodelling, and remains a standard entry point to the literature.[1]
Gene expression
A later strand of research moved from enzyme activity to transcriptional effects, examining how exposure to the complex altered expression across large numbers of genes in cultured cells. This work is mechanistically interesting but also where overstatement most often creeps in: observing a change in transcript levels in a cell culture model is a long way from establishing an outcome in a whole organism.
Handling and stability in the laboratory
GHK-Cu is supplied as a lyophilised solid and is stable in that form for extended periods when stored at −20°C, protected from light and moisture. Two handling points recur in the technical literature:
- Reconstitution should be gentle. Solvent is added slowly down the vial wall and the vial swirled rather than shaken or vortexed. Mechanical agitation introduces shear forces and air-liquid interfaces that can denature peptides.
- Copper complexes are light sensitive. Reconstituted material is normally refrigerated at 4°C, protected from light, and used within a short window.
Solution pH is also relevant, since the stability of the copper coordination depends on it. Buffer selection is worth considering explicitly rather than defaulting to whatever is on the bench.
What the literature does not establish
Honest summary matters more than enthusiasm here. The bulk of GHK-Cu research consists of in vitro work in cultured cells and a smaller body of animal studies. Cell culture results do not transfer automatically to intact tissue, where diffusion, protein binding and clearance all apply. Study designs vary widely in concentration ranges and exposure times, which makes direct comparison between papers difficult.
The 2026 systematic review is explicit that the case for expanded controlled trials has not yet been met by the existing evidence base.[3] That is a fair characterisation of where the field sits.
References
- Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008. PMID 18644225
- Siméon A. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. The Journal of Investigative Dermatology. 1999. PMID 10383745
- Najafi N. A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu in Topical Microneedle Delivery. Archives of Internal Medicine Research. 2026. PMID 42787770
Research use only
GHK-Cu is supplied by MMpeptides strictly for laboratory and in vitro research. It is not approved for human or veterinary use, is not a cosmetic or medicinal product, and nothing in this article should be read as describing use in people. Third-party studies are cited for scientific context only. Researchers are responsible for observing all applicable regulations in their jurisdiction.